335 related articles for article (PubMed ID: 9597417)
1. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.
Lilleberg J; Nieminen MS; Akkila J; Heikkilä L; Kuitunen A; Lehtonen L; Verkkala K; Mattila S; Salmenperä M
Eur Heart J; 1998 Apr; 19(4):660-8. PubMed ID: 9597417
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of levosimendan in the early stages of endotoxemia.
Cunha-Goncalves D; Perez-de-Sa V; Dahm P; Grins E; Thörne J; Blomquist S
Shock; 2007 Jul; 28(1):71-7. PubMed ID: 17510599
[TBL] [Abstract][Full Text] [Related]
3. Preoperative levosimendan in ischemic mitral valve repair.
Sharma P; Malhotra A; Gandhi S; Garg P; Bishnoi A; Gandhi H
Asian Cardiovasc Thorac Ann; 2014 Jun; 22(5):539-45. PubMed ID: 24867027
[TBL] [Abstract][Full Text] [Related]
4. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
Bragadottir G; Redfors B; Ricksten SE
Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
[TBL] [Abstract][Full Text] [Related]
5. Myocardial efficiency during levosimendan infusion in congestive heart failure.
Ukkonen H; Saraste M; Akkila J; Knuuti J; Karanko M; Iida H; Lehikoinen P; Någren K; Lehtonen L; Voipio-Pulkki LM
Clin Pharmacol Ther; 2000 Nov; 68(5):522-31. PubMed ID: 11103755
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
Anastasiadis K; Antonitsis P; Vranis K; Kleontas A; Asteriou C; Grosomanidis V; Tossios P; Argiriadou H
Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):740-747. PubMed ID: 27378790
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
Akgul A; Mavioglu L; Katircioglu SF; Pac M; Cobanoglu A
Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass.
Salgado Filho MF; Barral M; Barrucand L; Cavalcanti IL; Verçosa N
PLoS One; 2015; 10(12):e0143315. PubMed ID: 26655803
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake.
Michaels AD; McKeown B; Kostal M; Vakharia KT; Jordan MV; Gerber IL; Foster E; Chatterjee K
Circulation; 2005 Mar; 111(12):1504-9. PubMed ID: 15781741
[TBL] [Abstract][Full Text] [Related]
10. The use of the novel calcium sensitizer levosimendan in critically ill patients.
Plöchl W; Rajek A
Anaesth Intensive Care; 2004 Aug; 32(4):471-5. PubMed ID: 15675206
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
Metzsch C; Liao Q; Steen S; Algotsson L
Acta Anaesthesiol Scand; 2007 Jan; 51(1):86-93. PubMed ID: 17073861
[TBL] [Abstract][Full Text] [Related]
12. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.
Tritapepe L; De Santis V; Vitale D; Guarracino F; Pellegrini F; Pietropaoli P; Singer M
Br J Anaesth; 2009 Feb; 102(2):198-204. PubMed ID: 19151048
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of prophylactic levosimendan in high-risk valve surgery patients.
Ersoy O; Boysan E; Unal EU; Yay K; Yener U; Cicekcioglu F; Katircioglu F
Cardiovasc J Afr; 2013 Aug; 24(7):260-4. PubMed ID: 24217302
[TBL] [Abstract][Full Text] [Related]
15. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery.
Leppikangas H; Järvelä K; Sisto T; Maaranen P; Virtanen M; Lehto P; Karlsson S; Kööbi T; Lindgren L
Br J Anaesth; 2011 Mar; 106(3):298-304. PubMed ID: 21258075
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
17. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
Harkin CP; Pagel PS; Tessmer JP; Warltier DC
J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
[TBL] [Abstract][Full Text] [Related]
18. Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model.
du Toit E; Hofmann D; McCarthy J; Pineda C
Heart; 2001 Jul; 86(1):81-7. PubMed ID: 11410569
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients.
Atalay H; Temizturk Z; Altinsoy HB; Azboy D; Colak S; Atalay A; Dogan OF
Heart Surg Forum; 2016 Oct; 19(5):E230-E236. PubMed ID: 27801303
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and neurohumoral effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men.
Sundberg S; Lilleberg J; Nieminen MS; Lehtonen L
Am J Cardiol; 1995 May; 75(15):1061-6. PubMed ID: 7747690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
